Announcements Trials

Browse Landscape

Phase

Phase NA 8 Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 9 Breast Neoplasms 7 Neoplasms 4 Fatigue 3 Recurrence 2 Body Weight 2 Weight Loss 1 Warts 1 Vomiting 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Nausea 1 Multiple Myeloma 1 Lymphoma, Follicular 1 Lymphoma 1 Lung Neoplasms 1 Leukemia 1 Insulin Resistance 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Head and Neck Neoplasms 1 Dementia 1 Colonic Neoplasms 1 Cognitive Dysfunction 1 Asthenia 1 Anomia 1 Alzheimer Disease 1

Interventions

Cisplatin 47 Radiotherapy 37 Fluorouracil 23 Cetuximab 17 pembrolizumab 11 Carboplatin 11 Paclitaxel 8 Docetaxel 8 Radiotherapy, Intensity-Modulated 6 Chemotherapy, Adjuvant 6 Surgical Procedures, Operative 5 Standard of Care 5 nimotuzumab 4 Methotrexate 4 Gabapentin 4 Drug Therapy 4 Afatinib 4 Radiotherapy, Conformal 3 Radiation 3 Porfiromycin 3 Nivolumab 3 Neoadjuvant Therapy 3 Fibroblast Growth Factor 7 3 Bleomycin 3 zalutumumab 2 sargramostim 2 epacadostat 2 Tranexamic Acid 2 Tirapazamine 2 Pilocarpine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Head and Neck Neoplasms × Exercise × Clear all

NCT00696553 2011-07-27

ELAF

Vanderbilt University

Phase 3 Completed

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡